High levels of Sirt2 are observed in neurodegenerative disorders, including AD and PD [22], suggesting that Sirt2 inhibition may be a therapeutic strategy for the treatment of such diseases; this is further substantiated by the fact that Sirt2 inhibitors prevent neuronal loss [52]. Here, SIRT2 is linked to Parkinson disease.